Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry. The company resides in Graz, Austria. BIT Pharma develops and commercializes technologies for site-specific drug delivery to the central nervous system (CNS), in particular the brain, exploiting tailored drug delivery systems.
VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company. VALIDOGEN offers UNLOCK PICHIA - the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein production. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression. VALIDOGEN has established a broad range of tools and know-how for the generation of high-performance Pichia processes. Exclusive proprietary technologies and profound experience of the VALIDOGEN team lead to competitive production processes for a wide range of recombinant proteins. Headquartered in Raaba-Grambach, near Graz, Austria, VALIDOGEN is a private company and independent subsidiary of the KonValue Holding GmbH.
At SteadySense, we are using sensor technology in the global femtech fertility industry as well as creating diagnostic tools used in the early detection of infections utilising the enormous potential of sensor technology and continuous temperature measurement in the areas of medicine, healthcare and industry.
telbiomed specialises in the distribution of digital software platforms for health services. We design, implement and maintain the KeepInTouch (KIT) telehealth software of AIT Austrian Institute of Technology GmbH for healthcare providers, health insurers and pharmaceutical customers. We provide our customers with turnkey telehealth solutions that facilitate the collection of health data and the coordinated collaboration of all stakeholders: doctors, nurses, therapists, patients and care manager